fashion -WSS

fashion

author：hotspot 2025-10-01 00:47:32 - browse：4

Neurocrine Biosciences decided to join PhRMA. Adobe

WASHINGTON — Neurocrine Biosciences, a biotech company based in California, has joined the drug lobbying organization PhRMA, the group announced on Thursday.

The addition is a step toward rebuilding PhRMA’s ranks after high-profile departures that followed the passage of Democrats’ drug pricing law, though both Neurocrine and the other company that joined since are smaller than those that exited.

The company is a relatively big spender on lobbying, especially for its size. Neurocrine spent $3.1 million on its federal advocacy efforts last year alone. Compare that with Vertex Pharmaceuticals, which spent virtually the same amount on lobbying, even as it brought in nearly quadruple the net income that Neurocrine Biosciences did last year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Trump surgeon general acknowledges mistakes during Covid

leisure time

WSS

Ethical issues complicate the benefits of medical crowdfunding

'Make People Better': The CRISPR babies story you probably don't know

Myanmar's Supreme Court hears arguments in 2 appeals by ousted leader Aung San Suu Kyi

Accuser says Kevin Spacey grope wasn't a caress: ‘It was like a cobra ... angry’

3 protesters arrested at Wimbledon after interrupting matches by throwing confetti on court

How to protect patients from sexual assault

knowledge

fashion

hotspot

Medicare proposal to cover medical devices draws a mixed reaction

City of Memphis, police chief oppose effort to delay lawsuit in Tyre Nichols case

Activists slam private health insurers over coverage restrictions

Myanmar's Supreme Court hears arguments in 2 appeals by ousted leader Aung San Suu Kyi

How to save PrEP access — and even expand it

Adele warns fans about throwing things at performers onstage

Apple is now the first public company to be valued at $3 trillion

5 shark bites reported on Long Island as officials deploy surveillance drones

How to save PrEP access — and even expand it

Stem cell treatment guidelines are released by FDA

hotspot

'Make People Better': The CRISPR babies story you probably don't know

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

A new House health package & hospitals’ new site

House transparency, PBM reform bill gains bipartisan support

A bus careens into a gulch in southern Mexico, leaving 27 people dead

Medicaid rebukes states for mistakenly disenrolling children

leisure time

leisure time

leisure time

Wikipedia